Methanol → HCID 58904484, compound
Reaction equation
[CH3:1][C:2]1[CH:7]=[C:6]([CH3:8])[N:5]=[C:4]([O:9][C@@H:10]([C@@:14]2([C:27]3[CH:32]=[CH:31][CH:30]=[CH:29][CH:28]=3)[NH:20][CH2:19][C:18](=[O:21])[N:17]([CH3:22])[C:16]3[CH:23]=[CH:24][CH:25]=[CH:26][C:15]2=3)[C:11]([OH:13])=[O:12])[N:3]=1.[CH3:33]O>O.C=O.[Pd]>[CH3:22][N:17]1[C:16]2[CH:23]=[CH:24][CH:25]=[CH:26][C:15]=2[C@:14]([C@H:10]([O:9][C:4]2[N:3]=[C:2]([CH3:1])[CH:7]=[C:6]([CH3:8])[N:5]=2)[C:11]([OH:13])=[O:12])([C:27]2[CH:28]=[CH:29][CH:30]=[CH:31][CH:32]=2)[N:20]([CH3:33])[CH2:19][C:18]1=[O:21]Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 3
Procedure
Pd/C (100 mg, 10% Pd) is added to a solution of (±)-(S*)-(4,6-dimethyl-pyrimidin-2-yloxy)-((5S*)-1-methyl-2-oxo-5-phenyl-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-5-yl)-acetic acid (100 mg, 0.231 mmol, Example 49) in water (8 ml), methanol (8 ml) and aq. formaldehyde solution (0.2 ml, 36%). The mixture is stirred at rt under 3 atm H2 for 18 h before the catalyst is filtered off. The organic solvent of the filtrate is evaporated and the remaining aq. phase is extracted three times with DCM. The organic phase is evaporated and the product is purified by chromatography on prep. tlc-plattes with DCM:methanol 9:1 to give (±)-(S*)-((5S*)-1,4-dimethyl-2-oxo-5-phenyl-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-5-yl)-(4,6-dimethyl-pyrimidin-2-yloxy)-acetic acid (57 mg) as a white powder. LC-MS2: tR=3.40 min, [M+1]+=447.10, [M−1]−=445.14.
Workup
- filtrationis filtered off
- customThe organic solvent of the filtrate is evaporated
- extractionthe remaining aq. phase is extracted three times with DCM
- customThe organic phase is evaporated
- customthe product is purified by chromatography on prep
Sources & evidence
- ORD record
- ord-246b4b49e7514e2cb313bac7f3b1dcaa
- Source dataset
- uspto-grants-2007_07
- Patent number
- US07238685B2
Reaction notes
Loading…